Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
CAMP4 Therapeutics Corporation - Common Stock
(NQ:
CAMP
)
6.210
-0.920 (-12.90%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
691,346
Open
6.180
Bid (Size)
6.010 (100)
Ask (Size)
6.180 (100)
Prev. Close
7.130
Today's Range
5.986 - 7.000
52wk Range
1.305 - 7.690
Shares Outstanding
20,161,073
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
Today 7:10 EST
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
Today 7:00 EST
From
CAMP4 Therapeutics
Via
GlobeNewswire
Performance
YTD
+26.0%
+26.0%
1 Month
+57.2%
+57.2%
3 Month
+148.4%
+148.4%
6 Month
+343.6%
+343.6%
1 Year
+27.5%
+27.5%
More News
Read More
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company
↗
November 29, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity?
↗
November 18, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out
↗
November 18, 2025
Via
The Motley Fool
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 14, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
November 06, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
3 Healthcare Companies Insiders Are Buying
↗
October 14, 2025
Via
MarketBeat
Topics
Initial Public Offering
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
October 01, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 10, 2025
Via
Benzinga
Wednesday's after hours session: top gainers and losers
↗
September 10, 2025
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 10, 2025
Via
Benzinga
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
September 10, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
Camp4 Reports Q2 Revenue Beats Estimates
↗
August 14, 2025
Via
The Motley Fool
CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
August 14, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 28, 2025
Via
Benzinga
Sequans Appoints Jason W. Cohenour to Board of Directors
June 30, 2025
Via
Newsfile
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 11, 2025
Via
Benzinga
This Sandisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
May 27, 2025
Via
Benzinga
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American
May 16, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
May 13, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 06, 2025
Via
Benzinga
Why ThredUp Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
↗
May 06, 2025
Via
Benzinga
Frequently Asked Questions
Is CAMP4 Therapeutics Corporation - Common Stock publicly traded?
Yes, CAMP4 Therapeutics Corporation - Common Stock is publicly traded.
What exchange does CAMP4 Therapeutics Corporation - Common Stock trade on?
CAMP4 Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CAMP4 Therapeutics Corporation - Common Stock?
The ticker symbol for CAMP4 Therapeutics Corporation - Common Stock is CAMP on the Nasdaq Stock Market
What is the current price of CAMP4 Therapeutics Corporation - Common Stock?
The current price of CAMP4 Therapeutics Corporation - Common Stock is 6.210
When was CAMP4 Therapeutics Corporation - Common Stock last traded?
The last trade of CAMP4 Therapeutics Corporation - Common Stock was at 12/18/25 04:00 PM ET
What is the market capitalization of CAMP4 Therapeutics Corporation - Common Stock?
The market capitalization of CAMP4 Therapeutics Corporation - Common Stock is 125.20M
How many shares of CAMP4 Therapeutics Corporation - Common Stock are outstanding?
CAMP4 Therapeutics Corporation - Common Stock has 125M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.